Export 3 results:
Author Title Type [ Year(Asc)]
Filters: Author is George, Sarah L  [Clear All Filters]
2018
K. Modjarrad, Lin, L., George, S. L., Stephenson, K. E., Eckels, K. H., De La Barrera, R. A., Jarman, R. G., Sondergaard, E., Tennant, J., Ansel, J. L., Mills, K., Koren, M., Robb, M. L., Barrett, J., Thompson, J., Kosel, A. E., Dawson, P., Hale, A., C Tan, S., Walsh, S. R., Meyer, K. E., Brien, J., Crowell, T. A., Blazevic, A., Mosby, K., Larocca, R. A., Abbink, P., Boyd, M., Bricault, C. A., Seaman, M. S., Basil, A., Walsh, M., Tonwe, V., Hoft, D. F., Thomas, S. J., Barouch, D. H., and Michael, N. L., “Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.”, Lancet, vol. 391, no. 10120, pp. 563-571, 2018.
2015
S. L. George, Wong, M. A., Dube, T. J. T., Boroughs, K. L., Stovall, J. L., Luy, B. E., Haller, A. A., Osorio, J. E., Eggemeyer, L. M., Irby-Moore, S., Frey, S. E., Huang, C. Y. - H., and Stinchcomb, D. T., “Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.”, J Infect Dis, vol. 212, no. 7, pp. 1032-41, 2015.
2012
H. M. El Sahly, Davis, C., Kotloff, K., Meier, J., Winokur, P. L., Wald, A., Johnston, C., George, S. L., Brady, R. C., Lehmann, C., Stokes-Riner, A., and Keitel, W. A., “Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.”, J Infect Dis, vol. 205, no. 5, pp. 703-12, 2012.